Earle A. Chiles Research Institute

  • Targeted therapies are the focus of new studies for colorectal and bile duct cancers

    Targeted therapies are the focus of new studies for colorectal and bile duct cancers

    New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.

    Read Article
  • Cancer vaccine is focus of breast cancer study at Providence

    Cancer vaccine is focus of breast cancer study at Providence

    A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.

    Read Article
  • AACR Project GENIE: Making an impact worldwide in cancer research and precision medicine

    AACR Project GENIE: Making an impact worldwide in cancer research and precision medicine

    As part of an international data-sharing consortium of leading cancer centers, Providence Cancer Institute and Swedish Cancer Institute work together to provide genomic data to Project GENIE.

    Read Article
  • MRI-guided radiotherapy is a gamechanger in treating prostate cancer

    MRI-guided radiotherapy is a gamechanger in treating prostate cancer

    Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.

    Read Article
  • New study opens for non-GCB DLBCL patients under age 70

    New study opens for non-GCB DLBCL patients under age 70

    A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.

    Read Article
  • Three phases of clinical trials round out a year of research advancements

    Three phases of clinical trials round out a year of research advancements

    Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.

    Read Article
  • Fellowship trains next generation of immuno-oncology experts

    Fellowship trains next generation of immuno-oncology experts

    Providence currently accepting applications for an Immuno-Oncology Research Fellowship being offered through Earle A. Chiles Research Institute.

    Read Article
  • Providence immunologist honored at leading cancer conference

    Providence immunologist honored at leading cancer conference

    Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.

    Read Article
  • Providence among few sites worldwide offering new trials for solid tumors and lung cancer

    Providence among few sites worldwide offering new trials for solid tumors and lung cancer

    Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.

    Read Article
  •  Three new studies are focus of Breast Cancer Awareness Month

    Three new studies are focus of Breast Cancer Awareness Month

    Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.

    Read Article
  • New trial is first to study targeted therapy combination for treating thyroid cancer

    New trial is first to study targeted therapy combination for treating thyroid cancer

    New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.

    Read Article
  • loading
    Loading More...